Pediatr. praxi. 2013;14(4):221-224

Recurrent fever in children

MUDr.Petra Król, prof.MUDr.Pavla Doležalová, CSc.
Klinika dětského a dorostového lékařství, VFN a 1. LF UK, Praha

Recurrent fever in children may pose a major diagnostic challenge to pediatricians. In the last decade, a new group of diseases from the

category of autoinflammatory syndromes, whose main manifestation is periodic fever, has been included in the diagnostic algorithm.

These conditions are characterized by impairment of innate immune mechanisms. Recurrent fever episodes are accompanied by local

inflammatory processes. The majority of periodic fever syndromes are caused by a genetic disorder that induces excessive stimulation

of proinflammatory mechanisms. Cryopyrin-associated periodic syndromes (CAPS) and tumor necrosis factor receptor-associated

periodic syndrome (TRAPS) are characterized by autosomal dominant inheritance. Familial Mediterranean fever (FMF) and mevalonate

kinase-associated periodic syndrome (MAPS) are distinguished by autosomal recessive inheritance. Periodic fever, aphthous stomatitis,

pharyngitis, and adenitis (PFAPA), wherein the genetic background has not yet been determined, are outside this classification.

Keywords: periodic fever, innate immunity, inflammation

Published: August 29, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Król P, Doležalová P. Recurrent fever in children. Pediatr. praxi. 2013;14(4):221-224.
Download citation

References

  1. Marshall GS, Edwards KM, Butler J, Lawton AR. Syndrome of periodic fever, pharyngitis, and aphtous stomatitis. J. Pediatr. 1987; 110: 43-46. Go to original source... Go to PubMed...
  2. Marshall GS, Edwards KM, Lawton AR. PFAPA syndrome. Pediatr Infect Dis J. 1989; 8(9): 658-659. Go to original source... Go to PubMed...
  3. Feder HM. Periodic fever associated with aphtous stomatitis, pharyngitis and cervical adenitis. Pediatr Infect Dis J. 1989; 8: 186-187.
  4. Padeh S, Brezniak N, Zemer D, et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 1999; 135(1): 98-101. Go to original source... Go to PubMed...
  5. Thomas KT, Feder HM, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr. 1999; 135(1): 15-21. Go to original source... Go to PubMed...
  6. Long SS. Syndrome of periodic fever, aphtous stomatitis, pharyngitis, and adenitis (PFAPA) - what it isn't. What is it? J Pediatr. 1999; 135(1): 1-5. Go to original source... Go to PubMed...
  7. Hofer M, Cochard M, Anton J, et al. PFAPA (periodic fever, oral aphtae, pharyngitis and cervical adenitis) syndrome: a new consensus on diagnostic criteria. Ann Rheum Dis. 2009; 68(Suppl 3): 705.
  8. Berlucchi M, Meini A, Plebani A, et al. Update on treatment of Marshall's syndrome (PFAPA syndrome): report of five cases with review of the literature. Ann Otol Rhinol Laryngol. 2003; 112(4): 365-369. Go to original source... Go to PubMed...
  9. McDermott, MF, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell, 1999; 97(1): 133-144. Go to original source... Go to PubMed...
  10. Siebert S, et al. Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis Rheum, 2005; 52(4): 1287-1292. Go to original source... Go to PubMed...
  11. Drewe E, et al. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology (Oxford), 2003; 42(2): 235-239. Go to original source... Go to PubMed...
  12. van der Meer JW, Radl J, van Nieuwkoop JA, et al. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet, 1984; 19(1): 1087-1090. Go to original source... Go to PubMed...
  13. Drenth JP, et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet, 1999; 22(2): 178-181. Go to original source... Go to PubMed...
  14. Drenth JP, et al. Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group. Arch Dermatol, 1994; 130(1): 59-65. Go to original source... Go to PubMed...
  15. Drenth JP, Haagsma CJ, van der Meer JW. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore), 1994; 73(3): 133-144. Go to original source... Go to PubMed...
  16. Ozkaya N, Yalcinkaya F. Colchicine treatment in children with familial Mediterranean fever. Clin Rheumatol, 2003; 22(4-5): 314-317. Go to original source... Go to PubMed...
  17. Livneh A, et al. Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever. Nephron, 1992; 60(4): 418-422. Go to original source... Go to PubMed...
  18. Zemer D, et al. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med, 1986; 314(16): 1001-1005. Go to original source... Go to PubMed...
  19. Roldan R, et al. Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine. Joint Bone Spine, 2008; 75(4): 504-505. Go to original source... Go to PubMed...
  20. Moser C, et al. Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation. Nephrol Dial Transplant 2009; 24(2): 676-678. Go to original source... Go to PubMed...
  21. Aksentijevich I, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum, 2002; 46(12): 3340-3348. Go to original source... Go to PubMed...
  22. Boschan C, et al. Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment. Am J Med Genet A, 2006; 140(8): 883-886. Go to original source... Go to PubMed...
  23. Feldmann J, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet, 2002; 71(1): 198-203. Go to original source... Go to PubMed...
  24. Prieur AM, et al. A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol Suppl, 1987; 66: 57-68. Go to original source... Go to PubMed...
  25. Callejas JL, et al. Anakinra in mutation-negative CINCA syndrome. Clin Rheumatol 2007; 26(4): 576-577. Go to original source... Go to PubMed...
  26. Hawkins PN, et al. Response to anakinra in a de novo case of neonatal-onset multisystem inflammatory disease. Arthritis Rheum, 2004; 50(8): 2708-2709. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.